Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Enzymatica AB: ColdZyme study - Most recommended cold product at pharmacies

NewsLund, November 9, 2017 ColdZyme study - Most recommended cold product at pharmacies A new market survey shows that ColdZyme® Mouth Spray is the cold product that pharmacy staff in Sweden recommend most[[1]]. The majority of consumers who asked for help and recommendations at the pharmacy regarding colds were advised to use ColdZyme. In addition, recent statistics from Nielsen Data show that ColdZyme is the most successful brand launch of a new cold product[[2]] in over 30 years. The product has achieved a market share of 5 % (value) in the cold category since its launch in

MeaWallet signs new agreement with Norwegian bank

MeaWallet A/S (“MeaWallet”), part of Seamless Distribution AB (“Seamless”), has signed an agreement with a Norwegian bank for delivery of the Mea Token Platform. Deploying the Mea Token Platform, which is integrated to Mastercard Digital Enablement Service (MDES), will enable the bank’s customers to make smartphone payments in store, in app or on line, via any of the OEM Pays (i.e. Apple Pay, Samsung Pay, Fitbit Pay etc.). With a single point of integration to the Mea Token Platform, the bank will open up all of the OEM Pays to its customers. This is the first time MeaWallet deploys a

MIV-711 phase IIa osteoarthritis study data presented as a late breaking poster at the Annual Meeting of the American College for Rheumatology

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that data from the initial phase IIa study of MIV-711 in patients with moderate knee osteoarthritis were presented as a late-breaking poster at the 2017 annual meeting of the American College for Rheumatology (ACR), which took place from November 3-8 in San Diego, USA. The presentation, entitled “MIV-711, a Novel Cathepsin K Inhibitor Demonstrates Evidence of Osteoarthritis Structure Modification: Results from a 6 Month Randomised Double-Blind Placebo-Controlled Phase IIa Trial”, was made by Professor Philip Conaghan,

#17-525 Delisting of Instrument by Societe Generale Effekten GmbH

After the end of today’s trading, 1 instrument issued by Societe Generale Effekten GmbH will be terminated by the issuer and delisted from NDX Finland.For more details see attached files. For further information concerning this NDX notice please contact: NDX Listing on +46 8 566 390 10 or at ndxlist@ngm.se Nordic Growth Market NGM AB About NDX Nordic derivatives Exchange (NDX) is a market for listing and trading of derivatives and other structured products. The market is operated by Nordic Growth Market (www.ngm.se), a regulated exchange under the supervision of the Swedish

Positive EBITDA year-to-date driven by solid production

THIRD QUARTER Q3-2017 (vs Q3-2016) · Gold production was 94.1 kg (83.0) · Milled ore was 37,422 tonnes (36,104) at head grade of 3.0 g/t (2.7) · Cash Cost was 1,081 USD/oz (1,113) · Revenue was 27.6 MSEK (27.4) · EBITDA was 1.1 MSEK (1.3)   · Total cash flow was 1.6 (-7.4) · Profit after tax was -8.3 MSEK (-12.3) · Earnings per share was -0.79 SEK (-1.17) JANUARY-SEPTEMBER YTD-2017 (vs YTD-2016) · Gold production was 299.4 kg (215.2), +39 per cent, with the increase driven by higher gold grade, improved production efficiency and increased tonnage ·

Episurf Medical will exhibit at the 6th annual conference of the German Knee Society (DKG), held in Cologne, Germany, on November 24-26.

Episurf Medical (NASDAQ: EPIS B) will exhibit at 6th annual conference of the German Knee Society (DKG), held in Cologne, Germany (Gürzenich), on November 24-26. For full program, see http://knie-komplex.de/. For an overview of the industry conferences attended by Episurf Medical, see link. (www.episurf.com/healthcare-professionals/conferences). For more  information, please contact: Pål Ryfors, CEO, Episurf Medical Tel:+46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a

Update on Tawke PSC

9 November 2017 Genel Energy plc Update on Tawke PSC Genel Energy plc ('Genel') notes that DNO ASA, as operator of the Tawke PSC, has today issued an update on licence activity. The Peshkabir-3 well on the Tawke PSC is currently undergoing extended production testing across a horizontal section in excess of 1.2 kilometres of Cretaceous and Jurassic aged reservoirs. A total of ten oil zones and one gas zone have been identified for testing. The first oil zone tested flowed in excess of 3,000 bopd on a 64/64" choke. The Peshkabir-2 well continues to produce at a steady rate of

Vestas - Interim financial report, third quarter 2017

In the third quarter of 2017, Vestas generated revenue of EUR 2,743m – a decrease of 6 percent compared to the year-earlier period. EBIT decreased by EUR 78m to EUR 355m. The EBIT margin was 12.9 percent compared to 14.9 percent in the third quarter of 2016 and free cash flow* amounted to EUR 193m compared to EUR 155m in the third quarter of 2016.   The intake of firm and unconditional wind turbine orders amounted to 2,615 MW in the third quarter of 2017. The value of the wind turbine order backlog amounted to EUR 8.8bn as at 30 September 2017. In addition to the wind turbine order

Interim Report Period from January 2017 to September 2017

Peptonic Medical AB (publ) org nr 556776-3064 (www.aktietorget.se ticker: PMED) 2017 THIRD QUARTER (Jul-Sep) · Operating loss KSEK -2,969 (-1,983)  · Loss per share SEK -0.07 (-0.10) FIRST NINE MONTHS 2017 (Jan-Sep) · Operating loss KSEK -8,209 (-8,304)  · Loss per share SEK -0.19 (-0.40)  IMPORTANT EVENTS DURING THE PERIOD · On March 10th, the Company announced that the primary efficacy endpoints of the first part of its phase 2b study, in which the Vagitocin® gel was investigated for the treatment of vaginal atrophy, were not met. However, further analyses

Japanese publisher Asahi Interactive signs agreement for Cxense software

Oslo, Norway – 9 November 2017 – Cxense ASA (OSE: CXENSE) today announced that the leading Japanese online publisher Asahi Interactive Co., Ltd. signed an agreement with Cxense for use of data management and personalization software.Tokyo-based Asahi Interactive is a subsidiary of the Asahi Newspaper, operating various Japanese web sites providing news and information for people involved in technology and business. The company also operates the Japanese-speaking website for CNN and holds a license from CBS Interactive, Inc. to operate CNET Japan and ZDNet.Asahi Interactive will use the

Alfa Laval wins SEK 55 million refinery order

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won an order to supply welded heat exchangers to a refinery in the Middle East. The order has a value of approximately SEK 55 million. It is booked in the Welded Heat Exchangers business unit of the Energy Division, with deliveries scheduled for 2018.The Alfa Laval OLMI heat exchangers will be used for cooling applications in different process steps in the refinery. “I am very pleased to announce this large order for our welded heat exchangers,” says Susanne Pahlén Åklundh, President of the

ORGANOCLICK AB (PUBL) PUBLISHES ITS INTERIM REPORT FOR Q3 2017

"Our positive trend contnued during the third quarter with a total sales growth of 88 % and an organic sales growth of 47 % which amounted to total sales of SEK 16.5 million. The cash-flow from operations amounted to SEK -3.4 million compared with SEK -8.7 million during the same period 2016. Throught the directed emission of shares we increased our cash balance with SEK 38 million."Translation from CEO Mårten Hellbergs comments to the Interim Report.   Q3, 1 July – 30 September 2017 The Group compared with 2016 » The net revenue amounted to SEK 16.53 (8.78) million » EBITDA

Catena Media enters affiliate marketing with focus on financial services

As part of Catena Media's growth strategy, the company is expanding its offering by entering a regulated vertical for affiliate marketing focused on financial services. This by acquiring all affiliate related assets in the Malta based company Beyondbits Media Ltd (Beyondbits), including Aktiendepot.com  and Qomparo.de , among other sites.Catena Media acquires all affiliate related assets in Beyondbits. Beyondbits carefully monitors developments on the financial markets, providing information and facts, as well as comparing and

Inwido’s financial ambition is to increase operating EBITA by at least 10 percent annually

Inwido’s financial ambition continues to be to increase operating EBITA by at least 10 percent annually. This is the message that will be conveyed by Inwido’s President and CEO Håkan Jeppsson at the Group’s Capital Markets Day in Stockholm today. At the same time, he confirms that the financial targets remain in place.On the Capital Markets Day, the profitability target will be clarified as achieving an operating EBITA margin of 12 percent, given the phase of growth and acquisitions the Company is currently experiencing. For the near future, the ambition is to achieve operating EBITA margin

Episurf Medical will exhibit at the Sports Knee conference 2017, held in Burton-on-Trent, UK, on November 20-21

Episurf Medical (NASDAQ: EPIS B) will exhibit at Sports Knee conference 2017, held in Burton-on-Trent, UK (St George’s Park), on November 20-21. For full program, see http://sports-surgery.org/knee/sp_knee.php. For an overview of the industry conferences attended by Episurf Medical, see link. (www.episurf.com/healthcare-professionals/conferences). For more  information, please contact: Pål Ryfors, CEO, Episurf Medical Tel:+46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a

Interim report January-September 2017

Interim report January–September 2017 · Net asset value was SEK 126.50 per share, compared to SEK 101.74 at the end of the previous year, which represents an increase of 24.3 per cent. · Bure’s net asset value was SEK 8,770M, compared to SEK 7,054M at year-end 2016. · Total return on the Bure share was 10.2 per cent, compared to the SIX Return Index that rose by 12.5 per cent. · Consolidated profit after tax amounted to SEK 1,864M (2,178). Earnings per share stood at SEK 26.88 (31.41).   Comments from the CEO Bure’s net asset value per share increased 21.5 per cent in

Interim report – Third quarter of 2017

Attached please find the full report as PDF file. ________________________________________________________________________________ Announcement no. 8 9 November 2017   Interim report – third quarter of 2017 Today, the Board of Directors approved the interim report for the third quarter of 2017. The full report in English is attached as PDF file and contains the following highlights: · Results             Adjusted result for Q3 2017: USD 4 million (Q3 2016: USD -12 million)             - Dry Cargo: USD 5 million (USD -8 million)             - Tankers: USD -1

Clavister and the European Investment Bank in negotiations for up to EUR 20m in financing

Combined financing package of the European Investment Bank and Tagehus allows opportunity for Clavister to accelerate drive for global market share and best-in-class innovations.November 9, 2017. Örnsköldsvik, Sweden. Clavister (NASDAQ: CLAV), a leader in high-performance network security, today announced it’s in negotiations with the European Investment Bank (EIB) over a potential financing agreement of up to EUR 20m over multiple tranches. The agreement—which is subject to approvals being obtained by both parties and successful financial negotiations—gives Clavister the funding to pursue

Tethys Oil AB: Tethys Oil to be awarded new exploration license onshore Oman

Tethys Oil is pleased to announce that it will be awarded a new exploration license by the Ministry of Oil and Gas of the Sultanate of Oman. Block 49 is an onshore block that covers a prospective but still rather unexplored area in the South West of the Sultanate bordering the Kingdom of Saudi Arabia. Tethys Oil will through its wholly owned subsidiary Tethys Oil Montasar Ltd be the operator of the Block and hold a 100% of the license interest. The Block will be signed on 14 November 2017. The Block 49 licence covers an area of 15,439 square kilometres. More than 11,000 kilometres of 2D

Interim report for Q3 2017

We can now put eight quarters of rising sales based on rolling twelve-month figures behind us, which is very positive. This means that more and more patients have access to effective and safe infection prevention, not least in Sweden where we have recently won another tender. The value of delivered products increased by close to 50% in the quarter. Total revenues were essentially unchanged, but increased by 19% for the full nine-month period. EBITDA earnings were lower in the third quarter, but more than doubled for the nine-month period. At the same time, we generated a very strong cash flow

Eastnine publishes Interim Report for the third quarter 2017

Key events during the quarter: · Net Asset Value (NAV) per share was EUR 9.79, an increase of 2.2% from the second quarter¹. · All segments increased in value; Real Estate direct by 1.4%, Real Estate funds by 5.0% and Other by 1.5%. · Investments totalling EUR 8.0m were made in 3Burės development and East Capital Baltic Property Fund III. Divestments amounted to EUR 1.9m, referring to East Capital Deep Value Fund. · 577,013 shares were repurchased for a total of EUR 4.1m. · Decision on new dividend policy and financial targets to reflect the transformation into a real

MUNTERS THIRD QUARTER REPORT 2017

Strong development in Air Treatment and AgHort. Lumpy order intake and deliveries in Data Centers weighing on Group comparisons.Third quarter 2017 ·Order intake decreased by 6% to SEKm 1,489 (1,577) of which -4% organically. The third quarter 2016 included a SEKm 214 Data Center order received in August 2016. ·Net sales decreased by 0.5% to SEKm 1,552 (1,560) while organic growth was flat. Only a small portion of the record high Data Center backlog was delivered in the quarter, affecting also profitability. ·The order backlog increased by 14% to SEKm 2,332 (2,040).

NOTICE OF EXTRAORDINARY GENERAL MEETING IN CLAVISTER HOLDING AB

Clavister Holding AB will hold an Extraordinary General Meeting at 13:00 CET on Monday 11 December 2017 at the premises of the company, Sjögatan 6J in Örnsköldsvik. Registration begins at 12:00 CET.RIGHT TO ATTEND AND NOTIFICATION TO THE COMPANY Anyone wishing to attend the meeting must (i)                   be entered as a shareholder in the share register kept by Euroclear Sweden AB as of Tuesday, 5 December 2017; and (ii)                  give notice to the company of their intention to attend no later than Tuesday, 5 December 2017. Notification of attendance may be given by

CLAVISTER'S EXTRAORDINARY GENERAL MEETING IS PROPOSED TO RESOLVE ON ISSUE AUTHORIZATION, AMENDMENT OF ARTICLES OF ASSOCIATION AND MORE

The board of Clavister Holding AB (”Company") has decided to convene an extraordinary general meeting (the “EGM”) on Monday, December 11, 2017, as the Company is negotiating a credit facility of EUR 20,000,000 (the "EIB Loan") with the European Investment Bank (the "EIB"). To enable the Company to reach a favorable agreement with the EIB, the board proposes that the EGM authorizes the board (the “Issue Authorization”) to issue 1,800,000 warrants free of charge or at a subscription price of SEK 0.1 to the EIB, each entitling the EIB to subscribe for one (1) share in the Company at a strike

There are no items matching the current filter
There are no more items matching the current filter
Back to top